Buscar
Alector Inc
ALECAñadir a la lista de seguimiento
2.060USD
+0.050+2.49%
Cierre 07/02, 13:00（ET）Cotizaciones retrasadas 15 min
228.71MCap. mercado
PérdidaP/E TTM
Más Datos de Alector Inc Compañía
Alector, Inc. is a clinical-stage biotechnology company. The Company is focused on developing therapies to counteract the devastating progression of neurodegenerative diseases. It also develops alector brain carrier (ABC), a proprietary blood-brain barrier platform, which is applied to its next-generation product candidates and research pipeline. Its research and drug discovery platform leverages human genetic datasets, advanced tools in bioinformatics and imaging, and insights in neurodegeneration. Its clinical development portfolio includes latozinemab (AL001) and AL101/GSK4527226, while its preclinical and research pipeline candidates include ADP037-ABC, ADP050-ABC, ADP056, and ADP063-ABC/ADP064-ABC. Its first product candidate, latozinemab, is a human recombinant monoclonal antibody that increases the levels of progranulin (PGRN) in the brains of FTD-GRN patients. The AL101/GSK4527226, is a human recombinant monoclonal antibody designed to elevate PGRN levels in the brain.
Información de Alector Inc
Símbolo de cotizaciónALEC
Nombre de la empresaAlector Inc
Fecha de salida a bolsaFeb 07, 2019
Director ejecutivoRosenthal (Arnon)
Número de empleados238
Tipo de seguridadOrdinary Share
Fin del año fiscalFeb 07
Dirección131 Oyster Point Blvd., Suite 600
CiudadSOUTH SAN FRANCISCO
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal94080
Teléfono14152315660
Sitio Webhttps://alector.com
Símbolo de cotizaciónALEC
Fecha de salida a bolsaFeb 07, 2019
Director ejecutivoRosenthal (Arnon)
Ejecutivos de Alector Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Arnon Rosenthal, Ph.D.
Dr. Arnon Rosenthal, Ph.D.
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
5.63M
-1.55%
Dr. Saraswati (Sara) Kenkare-Mitra, Ph.D.
Dr. Saraswati (Sara) Kenkare-Mitra, Ph.D.
President, Head - Research and Development
President, Head - Research and Development
199.39K
+54.48%
Dr. Richard H. Scheller, Ph.D.
Dr. Richard H. Scheller, Ph.D.
Director
Director
106.20K
+37.23%
Dr. Kristine Yaffe
Dr. Kristine Yaffe
Independent Director
Independent Director
95.41K
+30.08%
Dr. Paula Hammond, Ph.D.
Dr. Paula Hammond, Ph.D.
Independent Director
Independent Director
74.91K
+38.31%
Mr. Mark Altmeyer
Mr. Mark Altmeyer
Independent Director
Independent Director
52.76K
+54.39%
Mr. Louis J. (Lou) Lavigne, Jr.
Mr. Louis J. (Lou) Lavigne, Jr.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. Elizabeth A. (Betsy) Garofalo, M.D.
Dr. Elizabeth A. (Betsy) Garofalo, M.D.
Independent Director
Independent Director
--
--
Dr. Errol De Souza, Ph.D.
Dr. Errol De Souza, Ph.D.
Independent Director
Independent Director
--
--
Mr. Giacomo Salvadore, M.D.
Mr. Giacomo Salvadore, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Arnon Rosenthal, Ph.D.
Dr. Arnon Rosenthal, Ph.D.
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
5.63M
-1.55%
Dr. Saraswati (Sara) Kenkare-Mitra, Ph.D.
Dr. Saraswati (Sara) Kenkare-Mitra, Ph.D.
President, Head - Research and Development
President, Head - Research and Development
199.39K
+54.48%
Dr. Richard H. Scheller, Ph.D.
Dr. Richard H. Scheller, Ph.D.
Director
Director
106.20K
+37.23%
Dr. Kristine Yaffe
Dr. Kristine Yaffe
Independent Director
Independent Director
95.41K
+30.08%
Dr. Paula Hammond, Ph.D.
Dr. Paula Hammond, Ph.D.
Independent Director
Independent Director
74.91K
+38.31%
Mr. Mark Altmeyer
Mr. Mark Altmeyer
Independent Director
Independent Director
52.76K
+54.39%
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Alector Inc?
Los cinco principales accionistas de Alector Inc son: Dr. Arnon Rosenthal, Ph.D.
¿Cuántas instituciones poseen acciones de Alector Inc (ALEC)?
A fecha de 2026Q1, 353 instituciones poseen acciones de Alector Inc, con un valor de mercado combinado de aproximadamente 89.88M, lo que representa el 80.95% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -32948606.00.